Nikolay Bogdanov

Suggest Changes
Learn More
BACKGROUND The study was aimed at comparative evaluation of seasonal influenza vaccine RIBSP versus commercial vaccine VAXIGRIP® for immunogenicity and safety in the course of clinical trial phase II(More)
  • 1